Table 1.
Baseline characteristics of patients n = 50.
| Characteristics | Patients, n (%) |
|---|---|
| Age, years | |
| Median age (range) | 61 (47-74) |
| <65 | 32 (64.0) |
| ≥65 | 18 (36.0) |
| Sex | |
| Male | 46 (92.0) |
| Female | 4 (8.0) |
| ECOG performance status score | |
| 0 | 14 (28.0) |
| 1 | 36 (72.0) |
| TNM staging | |
| IV | 50 (100.0) |
| Treatment cycles | |
| 1 | 7 (14.0) |
| 2 | 16 (32.0) |
| 3 | 2 (4.0) |
| 4 | 11 (22.0) |
| 5 | 1 (2.0) |
| 6 | 13 (26.0) |
| Previous treatment | |
| Paclitaxel and carboplatin | 17 (34.0) |
| Fluorouracil and oxaliplatin | 9 (18.0) |
| Docetaxel and cisplatin | 8 (16.0) |
| Fluorouracil and cisplatin | 5 (10.0) |
| Others | 11 (22.0) |
Data are expressed as n (%) unless otherwise indicated.